Exponent Inc Stock Price, News & Analysis

Exponent (Nasdaq: EXPO) reported third-quarter fiscal 2025 results for the period ended October 3, 2025. Q3 revenues rose 8% to $147.1M and revenues before reimbursements rose 10% to $137.1M. Net income was $28.0M, or $0.55 diluted EPS. EBITDA was $38.8M (28.3% of revenues before reimbursements). Year-to-date revenues rose 3% to $434.6M while net income decreased to $81.2M. The company paid $46.7M in dividends, repurchased $72.7M of stock, and ended the period with $207.4M cash. The Board approved a $100M increase to the buyback program and declared a $0.30 quarterly dividend.

Q4 and full-year 2025 guidance includes modest revenue growth and EBITDA margin ranges of 26.0%–27.0% (Q4) and 27.4%–27.65% (full year).

Exponent (Nasdaq: EXPO) will report Third Quarter fiscal 2025 results for the period ended October 3, 2025 after market close on Thursday, October 30, 2025. A conference call and webcast with CEO Dr. Catherine Corrigan and EVP/CFO Richard Schlenker will be held at 4:30 p.m. ET / 1:30 p.m. PT on the same day to discuss business and financial results.

Investors can join live by dialing (844) 481-2781 or (412) 317-0672, or listen via a live and archived webcast at the company Investor Relations site. A telephonic replay is available through Thursday, November 6, 2025 at (877) 344-7529 or (412) 317-0088 with passcode 1587971#.

Exponent (NASDAQ: EXPO) has declared a quarterly cash dividend of $0.30 per share for Q3 2025. The dividend will be paid on September 19, 2025, to stockholders of record as of September 5, 2025.

The company maintains its regular quarterly dividend schedule in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized the company's commitment to shareholder returns and highlighted Exponent's strong market position in safety, health, and environmental services.

Exponent (NASDAQ: EXPO) reported its Q2 2025 financial results with total revenues of $142.0 million, up 1% year-over-year. The company's revenues before reimbursements remained relatively flat at $132.9 million. Net income decreased to $26.6 million ($0.52 per diluted share) from $29.2 million ($0.57 per diluted share) in Q2 2024.

The engineering segment, representing 85% of revenues, grew 1% driven by dispute-related services in construction, automotive, and medical device sectors. The environmental and health segment declined 4%. EBITDA margin decreased to 27.8% from 30.2% year-over-year.

The company maintained its full-year 2025 guidance, expecting low single-digit growth in revenues and EBITDA margin between 26.50% to 27.0%. Exponent also announced a quarterly dividend of $0.30 per share.

Exponent (NASDAQ:EXPO) has scheduled its Second Quarter Fiscal Year 2025 earnings conference call for July 31, 2025, at 4:30 p.m. ET. The company will release its financial results for the period ended July 4, 2025, after market close on the same day.

CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will host the call. Investors can access the live call via phone or through a webcast on the company's investor relations website. A replay will be available until August 7, 2025.

Exponent Inc. (NASDAQ: EXPO) has declared a quarterly cash dividend of $0.30 per share for Q2 2025. The dividend will be paid on June 20, 2025 to stockholders of record as of June 6, 2025. The company maintains a regular quarterly dividend schedule in March, June, September, and December. CEO Dr. Catherine Corrigan emphasized that the dividend reflects their commitment to shareholder value, highlighting the company's diversified services portfolio as a strength in navigating market volatility while pursuing growth opportunities.

Exponent (NASDAQ: EXPO) reported its Q1 2025 financial results with total revenues remaining relatively flat at $145.5 million compared to Q1 2024. Net income decreased to $26.7 million ($0.52 per diluted share) from $30.1 million ($0.59 per diluted share) in Q1 2024. The company's engineering segment, representing 84% of revenues, remained flat, while the environmental and health segment grew 2%. EBITDA declined to $37.5 million (27.3% of net revenues) from $40.1 million. The company announced a quarterly dividend of $0.30 per share and maintained its 2025 guidance, expecting low-single-digit revenue growth despite facing Q2 headwinds. Exponent's performance was driven by increased dispute-related activities in chemicals, transportation, and utilities industries, though impacted by slowdown in consumer electronics.

Exponent Inc (Nasdaq: EXPO) has scheduled its First Quarter Fiscal Year 2025 financial results announcement for May 1, 2025, after market close. The company will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) on the same day.

CEO and President Dr. Catherine Corrigan and CFO Richard Schlenker will lead the discussion of the company's business and financial results for the period ended April 4, 2025. Investors can access the call through dial-in numbers (844) 481-2781 or (412) 317-0672.

A live and archived webcast will be available through the company's Investor Relations website. A replay of the call will be accessible until May 8, 2025, via (877) 344-7529 or (412) 317-0088 with passcode 8332346#.

Exponent (NASDAQ: EXPO) has announced a 7.1% increase in its quarterly cash dividend from $0.28 to $0.30 per share of common stock. The dividend will be paid on March 21, 2025, to stockholders of record as of March 7, 2025.

This marks the 12th consecutive year of dividend increases for the company. Exponent maintains a quarterly dividend schedule, with payments in March, June, September, and December, subject to Board approval. CEO Dr. Catherine Corrigan highlighted the company's commitment to shareholder value, emphasizing their diverse services portfolio and aligned operating model as key factors positioning them for market growth.